Schematic representation of the MAG-Tn3 vaccine. MAG-Tn3 is composed of a lysine core carrying four copies of the TT peptide further extended with a trimer of the Tn antigen.
The AS15 immunostimulant allows high anti-Tn antibody production in response to the MAG-Tn3 vaccine. HLA-DR1*A2 mice (n=4/group) were sc immunized with 10 µg of MAGTn3 (left panel) in association with Alum + CpG (1 mg Alum + 10 µg CpG 1826), AS01B (1/10 human dose) or AS15 immunostimulant (1/10 human dose), or with immunostimulant alone (right panel), on days 0, 21, 45 and 70. AS01B is a combination of 3-O-desacyl-4'-monophosphoryl lipid A (MPL, 50 µg, produced by GSK) and QS-21 (50 µg, Quillaja saponaria Molina, fraction 21 [Antigenics Inc, a wholly owned subsidiary of Agenus Inc., Lexington, MA, USA]) in a liposomal formulation. Sera were collected on days 21, 28, 52 and 80 and tested for Tn-specific IgG by ELISA using Tn3-G6K ( 
